136 related articles for article (PubMed ID: 32158439)
21. Insights on the Mechanism of Action of INH-C
Vila-Viçosa D; Victor BL; Ramos J; Machado D; Viveiros M; Switala J; Loewen PC; Leitão R; Martins F; Machuqueiro M
Mol Pharm; 2017 Dec; 14(12):4597-4605. PubMed ID: 29091448
[TBL] [Abstract][Full Text] [Related]
22. Preliminary structure-activity relationships and biological evaluation of novel antitubercular indolecarboxamide derivatives against drug-susceptible and drug-resistant Mycobacterium tuberculosis strains.
Onajole OK; Pieroni M; Tipparaju SK; Lun S; Stec J; Chen G; Gunosewoyo H; Guo H; Ammerman NC; Bishai WR; Kozikowski AP
J Med Chem; 2013 May; 56(10):4093-103. PubMed ID: 23611124
[TBL] [Abstract][Full Text] [Related]
23. Nitrooxidoreductase Rv2466c-Dependent Fluorescent Probe for Mycobacterium tuberculosis Diagnosis and Drug Susceptibility Testing.
Mu R; Kong C; Yu W; Wang H; Ma Y; Li X; Wu J; Somersan-Karakaya S; Li H; Sun Z; Liu G
ACS Infect Dis; 2019 Jun; 5(6):949-961. PubMed ID: 30916931
[TBL] [Abstract][Full Text] [Related]
24. [Detection and Molecular Analysis of Moxifloxacin MIC Values of Mycobacterium tuberculosis Strains Isolated from Clinical Specimens].
Bozok T; Kayar B; Yakıcı G; Eker E; Marzi M; Karslı F; Köksal F
Mikrobiyol Bul; 2019 Jul; 53(3):245-253. PubMed ID: 31414626
[TBL] [Abstract][Full Text] [Related]
25. Aspartate decarboxylase (PanD) as a new target of pyrazinamide in Mycobacterium tuberculosis.
Shi W; Chen J; Feng J; Cui P; Zhang S; Weng X; Zhang W; Zhang Y
Emerg Microbes Infect; 2014 Aug; 3(8):e58. PubMed ID: 26038753
[TBL] [Abstract][Full Text] [Related]
26. The resumption of consumption -- a review on tuberculosis.
Ducati RG; Ruffino-Netto A; Basso LA; Santos DS
Mem Inst Oswaldo Cruz; 2006 Nov; 101(7):697-714. PubMed ID: 17160276
[TBL] [Abstract][Full Text] [Related]
27. Mycothiol: a promising antitubercular target.
Nilewar SS; Kathiravan MK
Bioorg Chem; 2014 Feb; 52():62-8. PubMed ID: 24368170
[TBL] [Abstract][Full Text] [Related]
28. Bactericidal Disruption of Magnesium Metallostasis in Mycobacterium tuberculosis Is Counteracted by Mutations in the Metal Ion Transporter CorA.
Lopez Quezada L; Silve S; Kelinske M; Liba A; Diaz Gonzalez C; Kotev M; Goullieux L; Sans S; Roubert C; Lagrange S; Bacqué E; Couturier C; Pellet A; Blanc I; Ferron M; Debu F; Li K; Aubé J; Roberts J; Little D; Ling Y; Zhang J; Gold B; Nathan C
mBio; 2019 Jul; 10(4):. PubMed ID: 31289182
[TBL] [Abstract][Full Text] [Related]
29. Single nucleotide polymorphisms may explain the contrasting phenotypes of two variants of a multidrug-resistant Mycobacterium tuberculosis strain.
Bigi MM; Lopez B; Blanco FC; Sasiain MD; De la Barrera S; Marti MA; Sosa EJ; Fernández Do Porto DA; Ritacco V; Bigi F; Soria MA
Tuberculosis (Edinb); 2017 Mar; 103():28-36. PubMed ID: 28237031
[TBL] [Abstract][Full Text] [Related]
30. [Drug resistant tuberculosis].
Zwolska Z; Augustynowicz-Kopeć E
Pol Merkur Lekarski; 2011 May; 30(179):362-6. PubMed ID: 21675144
[TBL] [Abstract][Full Text] [Related]
31. A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis.
Stover CK; Warrener P; VanDevanter DR; Sherman DR; Arain TM; Langhorne MH; Anderson SW; Towell JA; Yuan Y; McMurray DN; Kreiswirth BN; Barry CE; Baker WR
Nature; 2000 Jun; 405(6789):962-6. PubMed ID: 10879539
[TBL] [Abstract][Full Text] [Related]
32. Novel, potent, orally bioavailable and selective mycobacterial ATP synthase inhibitors that demonstrated activity against both replicating and non-replicating M. tuberculosis.
Singh S; Roy KK; Khan SR; Kashyap VK; Sharma A; Jaiswal S; Sharma SK; Krishnan MY; Chaturvedi V; Lal J; Sinha S; Dasgupta A; Srivastava R; Saxena AK
Bioorg Med Chem; 2015 Feb; 23(4):742-52. PubMed ID: 25614114
[TBL] [Abstract][Full Text] [Related]
33. Killing of non-replicating Mycobacterium tuberculosis by 8-hydroxyquinoline.
Darby CM; Nathan CF
J Antimicrob Chemother; 2010 Jul; 65(7):1424-7. PubMed ID: 20435781
[TBL] [Abstract][Full Text] [Related]
34. Antimicrobial resistance in Mycobacterium tuberculosis: mechanistic and evolutionary perspectives.
Gygli SM; Borrell S; Trauner A; Gagneux S
FEMS Microbiol Rev; 2017 May; 41(3):354-373. PubMed ID: 28369307
[TBL] [Abstract][Full Text] [Related]
35. Potential of Zanthoxylum leprieurii as a source of active compounds against drug resistant Mycobacterium tuberculosis.
Bunalema L; Fotso GW; Waako P; Tabuti J; Yeboah SO
BMC Complement Altern Med; 2017 Feb; 17(1):89. PubMed ID: 28148252
[TBL] [Abstract][Full Text] [Related]
36. OPC-67683, a nitro-dihydro-imidazooxazole derivative with promising action against tuberculosis in vitro and in mice.
Matsumoto M; Hashizume H; Tomishige T; Kawasaki M; Tsubouchi H; Sasaki H; Shimokawa Y; Komatsu M
PLoS Med; 2006 Nov; 3(11):e466. PubMed ID: 17132069
[TBL] [Abstract][Full Text] [Related]
37. Scrutinizing the drug resistance mechanism of multi- and extensively-drug resistant
Ghajavand H; Kargarpour Kamakoli M; Khanipour S; Pourazar Dizaji S; Masoumi M; Rahimi Jamnani F; Fateh A; Yaseri M; Siadat SD; Vaziri F
Antimicrob Resist Infect Control; 2019; 8():70. PubMed ID: 31073401
[TBL] [Abstract][Full Text] [Related]
38. Rational Design of Biosafety Level 2-Approved, Multidrug-Resistant Strains of Mycobacterium tuberculosis through Nutrient Auxotrophy.
Vilchèze C; Copeland J; Keiser TL; Weisbrod T; Washington J; Jain P; Malek A; Weinrick B; Jacobs WR
mBio; 2018 May; 9(3):. PubMed ID: 29844114
[TBL] [Abstract][Full Text] [Related]
39. Ion Channel Blockers as Antimicrobial Agents, Efflux Inhibitors, and Enhancers of Macrophage Killing Activity against Drug Resistant Mycobacterium tuberculosis.
Machado D; Pires D; Perdigão J; Couto I; Portugal I; Martins M; Amaral L; Anes E; Viveiros M
PLoS One; 2016; 11(2):e0149326. PubMed ID: 26919135
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]